COMP <GO>
NEOG vs MRK // FREE CASH FLOW YIELD
Neogen Corporation (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: NEOG 0
— MRK 10
▲ FREE CASH FLOW YIELD LEADER: MRK
LAST: $11.82 (-3.59%) • MKT CAP: $2.68B
fcf-yield
3.11%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
fcf-yield
3.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEOG VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEOG | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.90% | 74.80% | -27.90 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -0.60% | 20.70% | -21.30 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 3.11% | 3.42% | -0.31 | MRK | /fcf-yield <GO> |
| Operating Margin | -2.50% | 34.30% | -36.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | -0.90% | 28.10% | -29.00 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | 1.30% | -4.00 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.45 | 5.19 | -3.74 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.6 | 51.7 | -0.10 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.68B | $361.02B | -$358.34B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEOG REV | MRK REV | NEOG GROSS % | MRK GROSS % | NEOG FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $870.4M | $65.01B | 46.9% | 74.8% | $83.2M | $12.36B |
| FY 2024 | $894.7M | $64.17B | 47.1% | 76.3% | $58.2M | $18.10B |
| FY 2023 | $924.2M | $60.12B | — | — | $35.3M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEOG // BETA —
MRK // BETA 0.92